Czech Republic - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)

Since 2014, Czech Republic Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) rose 2% year on year. At €132.23 Per Capita in 2019, the country was ranked number 13 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA). Czech Republic is overtaken by Greece, which was ranked number 12 at €163.59 Per Capita and is followed by Croatia at €131.84 Per Capita. Switzerland ranked the highest with €665.57 Per Capita in 2019, that is a growth of 3.2% compared to 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal witnessed the worst performance at -12.9% per year.

Loading...

Date Euros Per Capita
2019 132.23
2018 134.93
2017 128.11
2016 122.51
2015 120.18
Download all data from 2013 to 2019

How does Czech Republic rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?

# 23 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
665.57 2019 +3.1 % +5.3 % View data
2 #2
Germany
524.79 2019 +2.3 % +3.0 % View data
12 #12
Greece
163.59 2019 -8.8 % -1.7 % View data
13 #13
Czech Republic
132.23 2019 -2.0 % +2.0 % View data
14 #14
Croatia
131.84 2019 -1.4 % +2.2 % View data
Compare all 23 countries

Go Top